相似文献
1
Current advances in circulating inflammatory biomarkers in atherosclerosis and related cardio-cerebrovascular diseases.
Chronic Dis Transl Med. 2017 Nov 26;3(4):207-212. doi: 10.1016/j.cdtm.2017.09.002. eCollection 2017 Dec.
2
High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy.
Int J Cardiol. 2013 Oct 15;168(6):5126-34. doi: 10.1016/j.ijcard.2013.07.113. Epub 2013 Aug 24.
3
Postprandial lipoproteins and the molecular regulation of vascular homeostasis.
Prog Lipid Res. 2013 Oct;52(4):446-64. doi: 10.1016/j.plipres.2013.06.001. Epub 2013 Jun 15.
4
Indoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease.
BMC Nephrol. 2017 Jan 25;18(1):35. doi: 10.1186/s12882-017-0457-1.
5
Soluble urokinase plasminogen activator receptor is associated with inflammation in the vulnerable human atherosclerotic plaque.
Stroke. 2012 Dec;43(12):3305-12. doi: 10.1161/STROKEAHA.112.664094. Epub 2012 Nov 13.
6
[Prevalence and risk factors of extra-coronary artery disease in patients with diabetes which confirmed atherosclerosis of coronary arteries].
Kardiologiia. 2014;54(2):18-25. doi: 10.18565/cardio.2014.2.18-25.
7
Consolidated and emerging inflammatory markers in coronary artery disease.
World J Exp Med. 2015 Feb 20;5(1):21-32. doi: 10.5493/wjem.v5.i1.21.
8
Targeting LOX-1 in atherosclerosis and vasculopathy: current knowledge and future perspectives.
Ann N Y Acad Sci. 2019 May;1443(1):34-53. doi: 10.1111/nyas.13984. Epub 2018 Nov 1.
9
Diabetic vasculopathy and the lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1).
Curr Diabetes Rev. 2007 May;3(2):103-10. doi: 10.2174/157339907780598225.
10
Circulating Biomarkers Determining Inflammation in Atherosclerosis Progression.
Curr Med Chem. 2015;22(22):2619-35. doi: 10.2174/0929867322666150415125828.
引用本文的文献
1
An analytical method informed by clinical imaging data for estimating outlet boundary conditions in computational fluid dynamics analysis of carotid artery blood flow.
Sci Rep. 2023 Sep 11;13(1):14973. doi: 10.1038/s41598-023-42004-5.
2
The Induction of Endothelial Autophagy and Its Role in the Development of Atherosclerosis.
Front Cardiovasc Med. 2022 Mar 23;9:831847. doi: 10.3389/fcvm.2022.831847. eCollection 2022.
3
Atherosclerosis in HIV Patients: What Do We Know so Far?
Int J Mol Sci. 2022 Feb 24;23(5):2504. doi: 10.3390/ijms23052504.
4
Shear Stress-Induced Activation of von Willebrand Factor and Cardiovascular Pathology.
Int J Mol Sci. 2020 Oct 21;21(20):7804. doi: 10.3390/ijms21207804.
5
Association of Major Histocompatibility Complex Class I Related Chain A/B Positive Microparticles with Acute Myocardial Infarction and Disease Severity.
Diagnostics (Basel). 2020 Sep 29;10(10):766. doi: 10.3390/diagnostics10100766.
6
Mixed Lineage Kinase Domain-Like Protein Promotes Human Monocyte Cell Adhesion to Human Umbilical Vein Endothelial Cells Via Upregulation of Intercellular Adhesion Molecule-1 Expression.
Med Sci Monit. 2020 Aug 13;26:e924242. doi: 10.12659/MSM.924242.
7
Effect of Autophagy Regulated by Sirt1/FoxO1 Pathway on the Release of Factors Promoting Thrombosis from Vascular Endothelial Cells.
Int J Mol Sci. 2019 Aug 24;20(17):4132. doi: 10.3390/ijms20174132.
8
Association between gallstone and cardio-cerebrovascular disease: Systematic review and meta-analysis.
Exp Ther Med. 2019 Apr;17(4):3092-3100. doi: 10.3892/etm.2019.7291. Epub 2019 Feb 21.
9
Change of Inflammatory Factors in Patients with Acute Coronary Syndrome.
Chin Med J (Engl). 2018 Jun 20;131(12):1444-1449. doi: 10.4103/0366-6999.233953.
本文引用的文献
1
The Role of von Willebrand Factor in Vascular Inflammation: From Pathogenesis to Targeted Therapy.
Mediators Inflamm. 2017;2017:5620314. doi: 10.1155/2017/5620314. Epub 2017 May 28.
2
LOX-1 in Atherosclerosis and Myocardial Ischemia: Biology, Genetics, and Modulation.
J Am Coll Cardiol. 2017 Jun 6;69(22):2759-2768. doi: 10.1016/j.jacc.2017.04.010.
3
LOX-1 in Ischemic Stroke.
J Atheroscler Thromb. 2017 Jun 1;24(6):566-568. doi: 10.5551/jat.ED071. Epub 2017 Apr 25.
4
Evidence for the Involvement of Matrix-Degrading Metalloproteinases (MMPs) in Atherosclerosis.
Prog Mol Biol Transl Sci. 2017;147:197-237. doi: 10.1016/bs.pmbts.2017.01.004. Epub 2017 Mar 3.
5
Microparticles and their role in coronary artery disease.
Int J Cardiol. 2017 Mar 1;230:339-345. doi: 10.1016/j.ijcard.2016.12.108. Epub 2016 Dec 22.
6
Association of the LOX-1 rs1050283 Polymorphism with Risk for Atherosclerotic Cerebral Infarction and its Effect on sLOX-1 and LOX-1 Expression in a Chinese Population.
J Atheroscler Thromb. 2017 Jun 1;24(6):572-582. doi: 10.5551/jat.36327. Epub 2016 Nov 12.
7
Senescent intimal foam cells are deleterious at all stages of atherosclerosis.
Science. 2016 Oct 28;354(6311):472-477. doi: 10.1126/science.aaf6659. Epub 2016 Oct 27.
8
Chemokine RANTES is increased at early stages of coronary artery disease.
J Physiol Pharmacol. 2016 Apr;67(2):321-8.
9
LOX-1-Mediated Effects on Vascular Cells in Atherosclerosis.
Cell Physiol Biochem. 2016;38(5):1851-9. doi: 10.1159/000443123. Epub 2016 May 9.
10
Circulating Endothelial Microparticles: A Key Hallmark of Atherosclerosis Progression.
Scientifica (Cairo). 2016;2016:8514056. doi: 10.1155/2016/8514056. Epub 2016 Mar 15.
Zotero 插件